AxoGen, Inc.

NASDAQ:AXGN

9.79 (USD) • At close June 23, 2025
Bedrijfsnaam AxoGen, Inc.
Symbool AXGN
Munteenheid USD
Prijs 9.79
Beurswaarde 445,875,760
Dividendpercentage 0%
52-weken bereik 6.91 - 21
Industrie Medical Devices
Sector Healthcare
CEO Ms. Karen Zaderej
Website https://www.axogeninc.com

An error occurred while fetching data.

Over AxoGen, Inc.

AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector,

Vergelijkbare Aandelen

ADMA Biologics, Inc. logo

ADMA Biologics, Inc.

ADMA

17.87 USD

Tarsus Pharmaceuticals, Inc. logo

Tarsus Pharmaceuticals, Inc.

TARS

40.6 USD

Akoya Biosciences, Inc. logo

Akoya Biosciences, Inc.

AKYA

1.29 USD

Protagonist Therapeutics, Inc. logo

Protagonist Therapeutics, Inc.

PTGX

53.36 USD

Sight Sciences, Inc. logo

Sight Sciences, Inc.

SGHT

4.34 USD

OrganiGram Holdings Inc. logo

OrganiGram Holdings Inc.

OGI

1.28 USD

Repare Therapeutics Inc. logo

Repare Therapeutics Inc.

RPTX

1.41 USD

Agenus Inc. logo

Agenus Inc.

AGEN

4.8 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)